<?xml version="1.0" encoding="UTF-8"?>
<p>Inhibition of COX has been considered an important target of possible drugs for the treatment of inflammation [
 <xref rid="B35-molecules-25-03726" ref-type="bibr">35</xref>]. Inhibition of COX by agents such as acetylsalicylic acid seems to be responsible for the lack of balance of arachidonic acid metabolites, raising the products derived from lipoxygenase, leukotrienes, with bronchoconstriction and proinflammatory properties [
 <xref rid="B150-molecules-25-03726" ref-type="bibr">150</xref>].
</p>
